Flashpoint Batley: Anti-racism protesters hold rally against...

Although the company will continue to pursue "higher-risk, high reward" drug candidates such as pegilodecakin, these will be a smaller part of the portfolio in the future, said Chief Scientific Officer Daniel Skovronsky.

"This will be a significant cost saving for many of our urological patients with erectile dysfunction, including those experiencing side effects from diabetes or prostate cancer treatment," Dr Katz said in a statement on Thursday.

We didn't see him unmasked until 77-year-old Sebastian Shaw portrayed him briefly in 1983's "Return of the Jedi.